Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|October 6, 2000
Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomasG S Bauman, Y Ino, K Ueki, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 26, 1998
Long-term glioblastoma multiforme survivors: a population-based studyJ N Scott, N B Rewcastle, P M Brasher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosisY Ino, R A Betensky, M C Zlatescu, et al.Journal of Neurosurgery|May 1, 1999
The hPMS2 exon 5 mutation and malignant glioma. Case reportM D Taylor, J Perry, M C Zlatescu, et al.Journal of Neurosurgery|June 6, 2000
Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p lossY Ino, M C Zlatescu, H Sasaki, et al.Neuro-Oncology|April 17, 2001
Myeloablative chemotherapy for recurrent aggressive oligodendrogliomaG Cairncross, L Swinnen, R Bayer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic gliomaS C Schold, J E Herndon, P C Burger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasmsS C Schold, M S Mahaley, N A Vick, et al.Journal of Neurosurgery|February 1, 1994
Cognitive functioning in long-term survivors of high-grade gliomaY M Archibald, D Lunn, L A Ruttan, et al.Journal of the National Cancer Institute|October 17, 1998
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomasJ G Cairncross, K Ueki, M C Zlatescu, et al.Pageof 10